v3.26.1
Unaudited Condensed Statements of Changes in Shareholders’ (Deficit) Equity - USD ($)
Class B
Ordinary Shares
Additional Paid-In Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2024 [1],[2] $ 701 $ 24,299 $ 25,000
Balance (in Shares) at Dec. 31, 2024 [1],[2] 7,011,288      
Net income (loss)
Balance at Mar. 31, 2025 $ 701 24,299 25,000
Balance (in Shares) at Mar. 31, 2025 7,011,288      
Balance at Dec. 31, 2024 [1],[2] $ 701 24,299 25,000
Balance (in Shares) at Dec. 31, 2024 [1],[2] 7,011,288      
Net income (loss)       794,834
Balance at Jun. 30, 2025 $ 701 (9,417,575) (9,416,874)
Balance (in Shares) at Jun. 30, 2025 7,011,288      
Balance at Mar. 31, 2025 $ 701 24,299 25,000
Balance (in Shares) at Mar. 31, 2025 7,011,288      
Net income (loss)   794,834 794,834
Private Warrants, proceeds 3,821,591 3,821,591
Public warrants, fair value   4,557,833   4,557,833
Offering costs   (244,775)   (244,775)
Remeasurement   (18,371,357)   (18,371,357)
Reclassification of negative Additional Paid-In Capital   10,212,409 (10,212,409)
Balance at Jun. 30, 2025 $ 701 (9,417,575) (9,416,874)
Balance (in Shares) at Jun. 30, 2025 7,011,288      
Balance at Dec. 31, 2025 $ 701 (9,995,603) (9,994,902)
Balance (in Shares) at Dec. 31, 2025 7,011,288      
Net income (loss)     1,808,560 1,808,560
Remeasurement     (2,091,474) (2,091,474)
Balance at Mar. 31, 2026 $ 701 (10,278,517) (10,277,816)
Balance (in Shares) at Mar. 31, 2026 7,011,288      
Balance at Dec. 31, 2025 $ 701 (9,995,603) (9,994,902)
Balance (in Shares) at Dec. 31, 2025 7,011,288      
Net income (loss)       3,527,862
Balance at Jun. 30, 2026 $ 701 (10,664,898) (10,664,197)
Balance (in Shares) at Jun. 30, 2026 7,011,288      
Balance at Mar. 31, 2026 $ 701 (10,278,517) (10,277,816)
Balance (in Shares) at Mar. 31, 2026 7,011,288      
Net income (loss)     1,719,302 1,719,302
Remeasurement     (2,105,683) (2,105,683)
Balance at Jun. 30, 2026 $ 701 $ (10,664,898) $ (10,664,197)
Balance (in Shares) at Jun. 30, 2026 7,011,288      
[1] Includes an aggregate of up to 914,514 Class B ordinary shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters (see Note 5). No Class B ordinary shares were forfeited as the underwriters fully exercised the over-allotment option (see Note 5).
[2] Shares and associated accounts have been retroactively restated to reflect the surrender of 3,740,591 Class B ordinary shares to the Company for no consideration on March 13, 2025 and the issuance of an additional 1,168,548 Class B ordinary shares to the Sponsor for no consideration on May 14, 2025.